Anthony Atala to Cell Line, Tumor
This is a "connection" page, showing publications Anthony Atala has written about Cell Line, Tumor.
Connection Strength
1.766
-
Atala A. Re: Alterations of Tumor Microenvironment by Nitric Oxide Impedes Castration-Resistant Prostate Cancer Growth. J Urol. 2019 07; 202(1):35-36.
Score: 0.148
-
Atala A. Re: Classification of Prostate Cancer Using a Protease Activity Nanosensor Library. J Urol. 2019 05; 201(5):862-863.
Score: 0.147
-
Atala A. Re: Mg(II)-Catechin Nanoparticles Delivering siRNA Targeting EIF5A2 Inhibit Bladder Cancer Cell Growth In Vitro and In Vivo. J Urol. 2017 08; 198(2):258-259.
Score: 0.128
-
Atala A. Re: Infiltrating Macrophages Increase RCC Epithelial Mesenchymal Transition (EMT) and Stem Cell-Like Populations via AKT and mTOR Signaling. J Urol. 2017 01; 197(1):51-52.
Score: 0.123
-
Atala A. Re: N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. J Urol. 2016 11; 196(5):1584-1585.
Score: 0.122
-
Atala A. Re: Regulation of UHRF1 by Dual-Strand Tumor-Suppressor MicroRNA-145 (miR-145-5p and miR-145-3p): Inhibition of Bladder Cancer Cell Aggressiveness. J Urol. 2016 10; 196(4):1314.
Score: 0.121
-
Atala A. Re: Bone Metastasis in Prostate Cancer: Recurring Mitochondrial DNA Mutation Reveals Selective Pressure Exerted by the Bone Microenvironment. J Urol. 2016 09; 196(3):957-8.
Score: 0.121
-
Atala A. Re: Dietary Flavonoid Fisetin Binds to ß-Tubulin and Disrupts Microtubule Dynamics in Prostate Cancer Cells. J Urol. 2016 08; 196(2):618.
Score: 0.120
-
Atala A. Re: Sphaeropsidin A Shows Promising Activity against Drug-Resistant Cancer Cells by Targeting Regulatory Volume Increase. J Urol. 2016 07; 196(1):280-1.
Score: 0.119
-
Atala A. Re: Infiltrating Neutrophils Promote Renal Cell Carcinoma (RCC) Proliferation via Modulating Androgen Receptor (AR)???c-Myc Signals. J Urol. 2016 06; 195(6):1947-9.
Score: 0.119
-
Atala A. Re: Autophagy Defects Suggested by Low Levels of Autophagy Activator MAP1S and High Levels of Autophagy Inhibitor LRPPRC Predict Poor Prognosis of Prostate Cancer Patients. J Urol. 2016 06; 195(6):1948-9.
Score: 0.119
-
Atala A. Re: Tumour-Suppressive MicroRNA-29s Directly Regulate LOXL2 Expression and Inhibit Cancer Cell Migration and Invasion in Renal Cell Carcinoma. J Urol. 2016 May; 195(5):1622.
Score: 0.118
-
Atala A. Re: Human Schlafen 5 (SLFN5) is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells. J Urol. 2016 04; 195(4 Pt 1):1169.
Score: 0.117
-
Rajan SAP, Aleman J, Wan M, Pourhabibi Zarandi N, Nzou G, Murphy S, Bishop CE, Sadri-Ardekani H, Shupe T, Atala A, Hall AR, Skardal A. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform. Acta Biomater. 2020 04 01; 106:124-135.
Score: 0.039
-
Peak TC, Praharaj PP, Panigrahi GK, Doyle M, Su Y, Schlaepfer IR, Singh R, Vander Griend DJ, Alickson J, Hemal A, Atala A, Deep G. Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells. Biochem Biophys Res Commun. 2018 05 23; 499(4):1004-1010.
Score: 0.034
-
Skardal A, Devarasetty M, Forsythe S, Atala A, Soker S. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening. Biotechnol Bioeng. 2016 09; 113(9):2020-32.
Score: 0.030
-
Marcus K, Johnson M, Adam RM, O'Reilly MS, Donovan M, Atala A, Freeman MR, Soker S. Tumor cell-associated neuropilin-1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma. Neuropathology. 2005 Sep; 25(3):178-87.
Score: 0.014
-
Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res. 2005 May 01; 11(9):3530-4.
Score: 0.014
-
Doherty SC, McKeown SR, McKelvey-Martin V, Downes CS, Atala A, Yoo JJ, Simpson DA, Kaufmann WK. Cell cycle checkpoint function in bladder cancer. J Natl Cancer Inst. 2003 Dec 17; 95(24):1859-68.
Score: 0.013